Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.
about
Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primatesCurrent ebola vaccinesMucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responsesParticulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensMouse models for filovirus infectionsCombining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protectionEstablishment and characterization of a lethal mouse model for the Angola strain of Marburg virusProtective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteinsHuman Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.Ebola virus-like particles protect from lethal Ebola virus infection.Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines.Advances in virus-like particle vaccines for filoviruses.Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccinesAnthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores.Induction of ebolavirus cross-species immunity using retrovirus-like particles bearing the Ebola virus glycoprotein lacking the mucin-like domain.Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody ResponsesProspects for immunisation against Marburg and Ebola viruses.In silico prediction of Ebola Zaire GP(1,2) immuno-dominant epitopes for the Balb/c mouse.Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins.Filovirus-like particles as vaccines and discovery tools.Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers.Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityInduction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primatesHuman immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.Characterization of host immune responses in Ebola virus infections.Animal models for ebolavirus countermeasures discovery: what defines a useful model?Ebola vaccines in clinical trial: The promising candidates.High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus.Vesicular stomatitis virus pseudotyped with Ebola virus glycoprotein serves as a protective, non-infectious vaccine against Ebola virus challenge in mice.Updates on Treatment of Ebola Virus Disease.Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity.MhcDRB-sequences from cynomolgus macaques (Macaca fascicularis) of different origin.The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases.Antibodies to lipids and liposomes: immunology and safety.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
P2860
Q21131585-2A6B4D65-0CE7-4BD5-A7D6-CD5B84CC53A8Q21534720-A1D6E6FB-3C5E-4DF6-82B6-D27D8517E0F7Q21562420-7A5C9126-768F-45E9-804F-61B700611312Q27011190-B4E77E29-D853-49D1-B632-4F03D931CE67Q27011569-A1BBC8AF-25AF-457B-8082-9A04C14E2FD9Q27304818-9E0ACFA6-64F8-47DC-B050-8BC6FDF1911CQ33417197-E383AE72-5E06-476F-8ED3-175414B9647BQ34123838-1BACBA53-9D7B-4FBF-B240-45DC6BD2F218Q34463780-F67783DD-D682-42C6-BC50-AE57FEB2642EQ34774783-6E746DB0-86B5-4EAD-B52F-F796E5A3B248Q34792924-CCBE18BE-243D-4082-89D3-DA6B03BEE562Q34971349-0EBE41FB-6790-43CB-BCCA-AC8F26887305Q35023762-5D1A87EB-3EF5-4C61-B99C-3122D27859C1Q35300029-5F3911A3-974E-4296-A514-31E27968C979Q35635459-A9B4E55C-B8F6-4B57-B811-19F706E68DECQ35666215-AD9237A0-E9DD-4761-92F7-F60F3D6B1AF2Q35772032-FF388E99-F13B-4F95-97AD-4DA084D1986BQ36043254-9A049CD2-8FDE-41AB-91FD-6958A4FD4F20Q36088118-90806725-ED48-4E73-AA52-C181FE152C2AQ36130780-F6C2C35E-FBBA-487F-975A-D2B1E70D4DE0Q36138983-0D1D0EF9-C5DF-4BF6-B016-33026F40AF64Q36198685-57F6E74F-A519-4188-B219-D67E97B605A9Q36482804-580AD22A-7AAB-4B92-B8F9-C929664B7820Q36538834-A0A7965C-5171-4595-9CF5-12A2CEE17C5DQ36995725-58354C35-29D9-42AD-AE88-C035E2998E62Q37213207-614B018B-FB75-46C4-9F20-4D9743CC5CC3Q37247915-555B8AA4-3777-4894-810E-75403BC64ABAQ37976671-6C44E7B3-7910-433B-AC8C-20B83D11DD16Q38205274-479B6F70-FD69-45AB-AB0E-92CD66481DD7Q38500788-286723D6-9B72-4EDC-9B96-28C763D83C4AQ38808678-42381610-7B2B-4EBE-8B13-655E29D52E16Q39259533-6CF672DA-F4E3-4484-96A3-51C0CB8883A9Q40052567-CE8F73B5-8A50-48AC-8B88-082A307160B3Q40133255-1CA7DE9D-08C7-456C-95AA-F16D87E76627Q43013370-48FECB2A-ED05-49F5-A354-DE79BB3FE7A7Q46860008-23C0182A-FF15-4742-B722-887600D16DBFQ50124824-C711DF13-FFDD-483E-A571-A22968B9EA6DQ53601276-8A47998B-A908-426C-9259-3C264EDAAA57Q56535662-9D750D89-29F6-48C6-AFBD-48507B550722
P2860
Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Induction of immune responses ...... rotection in mice requires CD4
@nl
Induction of immune responses ...... mice requires CD4(+) T cells.
@ast
Induction of immune responses ...... mice requires CD4(+) T cells.
@en
type
label
Induction of immune responses ...... rotection in mice requires CD4
@nl
Induction of immune responses ...... mice requires CD4(+) T cells.
@ast
Induction of immune responses ...... mice requires CD4(+) T cells.
@en
prefLabel
Induction of immune responses ...... rotection in mice requires CD4
@nl
Induction of immune responses ...... mice requires CD4(+) T cells.
@ast
Induction of immune responses ...... mice requires CD4(+) T cells.
@en
P2093
P2860
P1433
P1476
Induction of immune responses ...... mice requires CD4(+) T cells.
@en
P2093
Carl R Alving
Gary R Matyas
Mangala Rao
P2860
P304
P356
10.1128/JVI.76.18.9176-9185.2002
P407
P577
2002-09-01T00:00:00Z